Real-time enrollment status for this colitis ulcerative clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 10:30 PM UTC
| NCT Number | NCT07463183 |
| Recruiting Status | Recruiting |
| Condition | Colitis Ulcerative |
| Phase | PHASE2 |
| Target Enrollment | 100 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | August 21, 2026 (6 days ago) |
As of August 27, 2026: Clinical trial NCT07463183 is currently recruiting participants. This phase2 study for colitis ulcerative is actively seeking new participants at 10 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07463183 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07463183 was last updated 6 days ago (August 21, 2026). HelloStudys verifies this status automatically.